{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "caspase", "colon cancer HCT 116 cells", "irinotecan", "phenethyl isothiocyanate"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37792803", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "26"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1002/tox.23993"], "Journal": {"ISSN": "1522-7278", "JournalIssue": {"Volume": "39", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan"}}, "Title": "Environmental toxicology", "ISOAbbreviation": "Environ Toxicol"}, "ArticleTitle": "Phenethyl isothiocyanate and irinotecan synergistically induce cell apoptosis in colon cancer HCT 116 cells in vitro.", "Pagination": {"StartPage": "457", "EndPage": "469", "MedlinePgn": "457-469"}, "Abstract": {"AbstractText": ["Irinotecan (IRI), an anticancer drug to treat colon cancer patients, causes cytotoxic effects on normal cells. Phenethyl isothiocyanate (PEITC), rich in common cruciferous plants, has anticancer activities (induction of cell apoptosis) in many human cancer cells, including colon cancer cells. However, the anticancer effects of IRI combined with PEITC on human colon cancer cells in vitro were unavailable. Herein, the aim of this study is to focus on the apoptotic effects of the combination of IRI and PEITC on human colon cancer HCT 116 cells in vitro. Propidium iodide (PI) exclusion and Annexin V/PI staining assays showed that IRI combined with PEITC decreased viable cell number and induced higher cell apoptosis than that of IRI or PEITC only in HCT 116 cells. Moreover, combined treatment induced higher levels of reactive oxygen species (ROS) and Ca<sup>2+</sup> than that of IRI or PEITC only. Cells pre-treated with N-acetyl-l-cysteine (scavenger of ROS) and then treated with IRI, PEITC, or IRI combined with PEITC showed increased viable cell numbers than that of IRI or PEITC only. IRI combined with PEITC increased higher caspase-3, -8, and -9 activities than that of IRI or PEITC only by flow cytometer assay. IRI combined with PEITC induced higher levels of ER stress-, mitochondria-, and caspase-associated proteins than that of IRI or PEITC treatment only in HCT 116 cells. Based on these observations, PEITC potentiates IRI anticancer activity by promoting cell apoptosis in the human colon HCT 116 cells. Thus, PEITC may be a potential enhancer for IRI in humans as an anticolon cancer drug in the future."], "CopyrightInformation": "\u00a9 2023 Wiley Periodicals LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, Tainan, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Surgery, China Medical University Beigang Hospital, Beigang, Yunlin, Taiwan."}], "LastName": "Lai", "ForeName": "Kuang-Chi", "Initials": "KC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan."}], "LastName": "Chueh", "ForeName": "Fu-Shin", "Initials": "FS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine for Post-Baccalaureate, College of Medicine, I-Shou University, Kaohsiung, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Chinese Medicine, E-Da Cancer Hospital, Kaohsiung, Taiwan."}], "LastName": "Ma", "ForeName": "Yi-Shih", "Initials": "YS"}, {"Identifier": ["0000-0002-2359-9883"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan."}], "LastName": "Chou", "ForeName": "Yu-Cheng", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan."}], "LastName": "Chen", "ForeName": "Jaw-Chyun", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan."}], "LastName": "Liao", "ForeName": "Ching-Lung", "Initials": "CL"}, {"Identifier": ["0000-0003-0775-9880"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Medicine, China Medical University, Taichung, Taiwan."}], "LastName": "Huang", "ForeName": "Yi-Ping", "Initials": "YP"}, {"Identifier": ["0000-0002-1792-0474"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Research, China Medical University Hospital, Taichung, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Biological Science and Technology, China Medical University, Taichung, Taiwan."}], "LastName": "Peng", "ForeName": "Shu-Fen", "Initials": "SF"}], "GrantList": [{"GrantID": "DMR-110-147", "Agency": "China Medical University Hospital", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Toxicol", "NlmUniqueID": "100885357", "ISSNLinking": "1520-4081"}, "ChemicalList": [{"RegistryNumber": "6U7TFK75KV", "NameOfSubstance": "phenethyl isothiocyanate"}, {"RegistryNumber": "7673326042", "NameOfSubstance": "Irinotecan"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Isothiocyanates"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Irinotecan"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Isothiocyanates"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Colonic Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Atawodi SE. Nigerian foodstuffs with prostate cancer chemopreventive polyphenols. Infect Agent Cancer. 2011;6(suppl 2):S9."}, {"Citation": "Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145-164."}, {"Citation": "Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669-685."}, {"Citation": "Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254."}, {"Citation": "Ministry of Health and Welfare. 2022 Statistics of causes of death. 2023. https://www.mohw.gov.tw/cp-6563-74869-1.html"}, {"Citation": "Edwards MS, Chadda SD, Zhao Z, Barber BL, Sykes DP. A systematic review of treatment guidelines for metastatic colorectal cancer. Colorectal Dis. 2012;14(2):e31-e47."}, {"Citation": "Fuchs C, Mitchell EP, Hoff PM. Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev. 2006;32(7):491-503."}, {"Citation": "Ychou M, Raoul JL, Desseigne F, et al. High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer. Cancer Chemother Pharmacol. 2002;50(5):383-391."}, {"Citation": "Hecht JR. Gastrointestinal toxicity or irinotecan. Oncology (Williston Park). 1998;12(8 suppl 6):72-78."}, {"Citation": "Gustavsson B, Carlsson G, Machover D, et al. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer. 2015;14(1):1-10."}, {"Citation": "Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343(13):905-914."}, {"Citation": "Bayat Mokhtari R, Homayouni TS, Baluch N, et al. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022-38043."}, {"Citation": "Perkins S, Verschoyle RD, Hill K, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002;11(6):535-540."}, {"Citation": "Ju J, Hong J, Zhou JN, et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (\u2212)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 2005;65(22):10623-10631."}, {"Citation": "Lv H, Zhen C, Liu J, Shang P. \u03b2-Phenethyl isothiocyanate induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the MAPK signaling pathway. Oxid Med Cell Longev. 2020;2020:5021983."}, {"Citation": "Chen H, Yang N, Yu L, et al. Synergistic microbicidal effect of AUR and PEITC against Staphylococcus aureus skin infection. Front Cell Infect Microbiol. 2022;12:927289."}, {"Citation": "Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309-324."}, {"Citation": "Soundararajan P, Kim JS. Anti-carcinogenic glucosinolates in cruciferous vegetables and their antagonistic effects on prevention of cancers. Molecules. 2018;23(11):2983."}, {"Citation": "Coscueta ER, Sousa AS, Reis CA, Pintado MM. Phenylethyl isothiocyanate: a bioactive agent for gastrointestinal health. Molecules. 2022;27:27(3)."}, {"Citation": "Hsu SY, Lee SC, Liu HC, et al. Phenethyl isothiocyanate suppresses the proinflammatory cytokines in human glioblastoma cells through the PI3K/Akt/NF-\u03baB signaling pathway in vitro. Oxid Med Cell Longev. 2022;2022:2108289."}, {"Citation": "Chou YC, Chang MY, Wang MJ, et al. PEITC induces apoptosis of human brain glioblastoma GBM8401 cells through the extrinsic- and intrinsic-signaling pathways. Neurochem Int. 2015;81:32-40."}, {"Citation": "Chen PY, Lin KC, Lin JP, et al. Phenethyl isothiocyanate (PEITC) inhibits the growth of human oral squamous carcinoma HSC-3 cells through G(0)/G(1) phase arrest and mitochondria-mediated apoptotic cell death. Evid Based Complement Alternat Med. 2012;2012:718320."}, {"Citation": "Aggarwal M, Saxena R, Sinclair E, et al. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth. Cell Death Differ. 2016;23(10):1615-1627."}, {"Citation": "Liu KC, Shih TY, Kuo CL, et al. Sulforaphane induces cell death through G2/M phase arrest and triggers apoptosis in HCT 116 human colon cancer cells. Am J Chin Med. 2016;44(6):1289-1310."}, {"Citation": "Maraming P, Klaynongsruang S, Boonsiri P, et al. The cationic cell-penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells. J Cell Physiol. 2019;234(12):22116-22129."}, {"Citation": "Hsiao YT, Kuo CL, Lin JJ, et al. Curcuminoids combined with gefitinib mediated apoptosis and autophagy of human oral cancer SAS cells in vitro and reduced tumor of SAS cell xenograft mice in vivo. Environ Toxicol. 2018;33:821-832."}, {"Citation": "Zeynali P, Jazi MS, Asadi J, Jafari SM. A1 adenosine receptor antagonist induces cell apoptosis in KYSE-30 and YM-1 esophageal cancer cell lines. Biomedicine. 2023;13(1):54-61."}, {"Citation": "Kuo JY, Liao CL, Ma YS, et al. Combination treatment of sorafenib and bufalin induces apoptosis in NCI-H292 human lung cancer cells in vitro. In Vivo. 2022;36(2):582-595."}, {"Citation": "Lee MR, Lin C, Lu CC, et al. YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells. Biomedicine. 2017;7(2):12."}, {"Citation": "Hsiao YT, Kuo CL, Chueh FS, Liu KC, Bau DT, Chung JG. Curcuminoids induce reactive oxygen species and autophagy to enhance apoptosis in human oral cancer cells. Am J Chin Med. 2018;46(5):1145-1168."}, {"Citation": "Huang WW, Chiu YJ, Fan MJ, et al. Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells. Mol Nutr Food Res. 2010;54(11):1585-1595."}, {"Citation": "Wang Z, Wei Y, Fang G, et al. Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-\u03b5-poly(caprolactone) nanocarriers. Drug des Devel Ther. 2018;12:3171-3180."}, {"Citation": "Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Food groups and risk of colorectal cancer. Int J Cancer. 2018;142(9):1748-1758."}, {"Citation": "Gupta R, Bhatt LK, Momin M. Potent antitumor activity of Laccaic acid and phenethyl isothiocyanate combination in colorectal cancer via dual inhibition of DNA methyltransferase-1 and histone deacetylase-1. Toxicol Appl Pharmacol. 2019;377:114631."}, {"Citation": "Gupta P, Wright SE, Srivastava SK. PEITC treatment suppresses myeloid derived tumor suppressor cells to inhibit breast tumor growth. Onco Targets Ther. 2015;4(2):e981449."}, {"Citation": "Yuan JM, Stepanov I, Murphy SE, et al. Clinical trial of 2-phenethyl isothiocyanate as an inhibitor of metabolic activation of a tobacco-specific lung carcinogen in cigarette smokers. Cancer Prev Res (Phila). 2016;9(5):396-405."}, {"Citation": "Liu KC, Lin YJ, Hsiao YT, et al. Tetrandrine induces apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells by endoplasmic reticulum stress and Ca(2+)/calpain pathways. Anticancer Res. 2017;37(11):6107-6118."}, {"Citation": "Lee CH, Shih YL, Lee MH, et al. Bufalin induces apoptosis of human osteosarcoma U-2 OS cells through endoplasmic reticulum stress, caspase- and mitochondria-dependent signaling pathways. Molecules. 2017;22(3):437."}, {"Citation": "Huang YF, Zhu DJ, Chen XW, et al. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Oncotarget. 2017;8(25):40264-40275."}, {"Citation": "Hoffman JD, Ward WM, Loo G. Effect of antioxidants on the genotoxicity of phenethyl isothiocyanate. Mutagenesis. 2015;30(3):421-430."}, {"Citation": "Sun SY. N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol Ther. 2010;9(2):109-110."}, {"Citation": "Afrin S, Okuma E, Tahjib-Ul-Arif M, et al. Stomatal response to isothiocyanates in Arabidopsis thaliana. J Exp Bot. 2020;71(22):6921-6931."}, {"Citation": "Kerkhofs M, Bittremieux M, Morciano G, et al. Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes. Cell Death Dis. 2018;9(3):334."}, {"Citation": "Lin YJ, Peng SF, Lin ML, et al. Tetrandrine induces apoptosis of human nasopharyngeal carcinoma NPC-TW 076 cells through reactive oxygen species accompanied by an endoplasmic reticulum stress signaling pathway. Molecules. 2016;21(10):1353."}, {"Citation": "Sukumaran P, Schaar A, Sun Y, Singh BB. Functional role of TRP channels in modulating ER stress and autophagy. Cell Calcium. 2016;60(2):123-132."}, {"Citation": "Wang Y, Guo SH, Shang XJ, et al. Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response. Acta Pharmacol Sin. 2018;39(2):311-327."}, {"Citation": "Zhang Y, Chen F. Reactive oxygen species (ROS), troublemakers between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK). Cancer Res. 2004;64(6):1902-1905."}, {"Citation": "Huang YP, Jiang YW, Chen HY, et al. Benzyl isothiocyanate induces apoptotic cell death through mitochondria-dependent pathway in gefitinib-resistant NCI-H460 human lung cancer cells in vitro. Anticancer Res. 2018;38(9):5165-5176."}, {"Citation": "Hu Y, Wen Q, Cai Y, et al. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway. Phytomedicine. 2023;108:154528."}, {"Citation": "Hu YX, Liu Z, Zhang Z, et al. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans. World J Gastroenterol. 2023;29(12):1875-1898."}, {"Citation": "Inoue T, Aoyama-Ishikawa M, Uemura M, et al. Interleukin-18 levels and mouse Leydig cell apoptosis during lipopolysaccharide-induced acute inflammatory conditions. J Reprod Immunol. 2020;141:103167."}, {"Citation": "Pai P, Lai CJ, Lin CY, Liou YF, Huang CY, Lee SD. Effect of superoxide anion scavenger on rat hearts with chronic intermittent hypoxia. J Appl Physiol. 2016;120(8):982-990."}, {"Citation": "Bian Y, Wang H, Sun S. Taurine alleviates endoplasmic reticulum stress in the chondrocytes from patients with osteoarthritis. Redox Rep. 2018;23(1):118-124."}, {"Citation": "Kopp MC, Larburu N, Durairaj V, Adams CJ, Ali MMU. UPR proteins IRE1 and PERK switch BiP from chaperone to ER stress sensor. Nat Struct Mol Biol. 2019;26(11):1053-1062."}, {"Citation": "Haze K, Okada T, Yoshida H, et al. Identification of the G13 (cAMP-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response. Biochem J. 2001;355(Pt 1):19-28."}, {"Citation": "Urano F, Wang X, Bertolotti A, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287(5453):664-666."}, {"Citation": "Bracken C, Beauverger P, Duclos O, et al. CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of nephronophthisis. Am J Physiol Renal Physiol. 2016;310(11):F1414-F1422."}, {"Citation": "Toth A, Nickson P, Mandl A, Bannister ML, Toth K, Erhardt P. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets. 2007;7(3):205-218."}, {"Citation": "Wan Y, Xin Y, Zhang C, et al. Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway. Oncol Lett. 2014;7(5):1738-1742."}, {"Citation": "Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol. 2008;9(5):378-390."}, {"Citation": "Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16(2):99-109."}, {"Citation": "Yasuhara N, Sahara S, Kamada S, Eguchi Y, Tsujimoto Y. Evidence against a functional site for Bcl-2 downstream of caspase cascade in preventing apoptosis. Oncogene. 1997;15(16):1921-1928."}, {"Citation": "Cheng EH, Kirsch DG, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 1997;278(5345):1966-1968."}, {"Citation": "Clem RJ, Cheng EH, Karp CL, et al. Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA. 1998;95(2):554-559."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "8", "Day": "29"}, {"Year": "2023", "Month": "7", "Day": "18"}, {"Year": "2023", "Month": "9", "Day": "21"}, {"Year": "2023", "Month": "12", "Day": "26", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "10", "Day": "4", "Hour": "18", "Minute": "42"}, {"Year": "2023", "Month": "10", "Day": "4", "Hour": "13", "Minute": "45"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37792803", "10.1002/tox.23993"]}}], "PubmedBookArticle": []}